AKAP18δ Anchors and Regulates CaMKII Activity at Phospholamban-SERCA2 and RYR is a research paper published in Circulation Research (2021). On theSindex it has a DataRank of 0. It has been cited 59 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | National Institutes of Health
Grant: R01- HL133832
HHS | National Institutes of Health
Grant: R01-HL142282
Deutsche Forschungsgemeinschaft
Grant: KL1415/7-1
Deutsche Forschungsgemeinschaft
Grant: 394046635 - SFB 1365
the Bundesministerium für Bildung und Forschung
Grant: 16GW0179K
the German Israeli Foundation
Grant: I-1452-203/13-2018
NHLBI NIH HHS
Grant: R01 HL142282
NHLBI NIH HHS
Grant: R01 HL092097
NHLBI NIH HHS
Grant: R01 HL133832
Deutsche Forschungsgemeinschaft
Grant: 394046635/SFB 1365
Renoprotection
National Institutes of Health
Grant: 5R01HL133832-02
AKAP-dependent regulation of Cardiac SR Ca handling
Deutsche Forschungsgemeinschaft
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01HL142282-03
CaMKII activation and regulation in adult cardiac myocytes
Anders Jahres Fond til Vitenskapens Fremme
Nasjonalforeningen for Folkehelsen
UNIFOR-FRIMED
South-Eastern Norway Regional Health Authority
Stiftelsen Kristian Gerhard Jebsen
The Research Council of Norway
FWCI
6.87
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics
Additional file 1 of M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics
Additional file 2 of M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics
Additional file 2 of M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics
Additional file 3 of M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics
Additional file 3 of M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics
Additional file 4 of M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics
Additional file 4 of M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics
Additional file 6 of M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics
Additional file 6 of M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics
Additional file 5 of M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics
Additional file 5 of M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics